HOME >> MEDICINE >> NEWS
Pediatricians can help immigrant mothers by explaining child development, NICHD study suggests

Groups of immigrant mothers from Japan and South America knew less about child development than did their European American counterparts, according to a study by researchers at the National Institute of Child Health and Human Development of the National Institutes of Health.

Such gaps in parenting knowledge, the authors wrote in the November issue of Pediatrics, could have a negative impact on children's development, with mothers possibly missing warning signs that their children need medical attention or early intervention services.

The authors added that pediatricians could assist parents who lack knowledge of child development by taking steps to educate them about the topic.

The study was conducted by Marc Bornstein, Ph.D., and Linda Cote, Ph.D., C.F.L.E., both of NICHD's Section on Child and Family Research.

The researchers pointed out, however, that the immigrant mothers knew as much about health practices concerning their children's physical safety as did the European American mothers.

"New parents have a need for accurate and helpful information about child development and pediatricians can help meet that need," said NICHD Director Duane Alexander, M.D. "In turn, parents who have an understanding of child development can provide pediatricians with information that will help them better serve pediatric patients."

In the article, the researchers wrote that study of child rearing practices among immigrants is extremely important because a large proportion of U.S. children come from immigrant families. The researchers cited a U.S. Census Bureau statistic that roughly 1 in 5 U.S. children, about 14 million in all, lives with at least 1 immigrant parent. The researchers added that they chose to study Asian and Latino mothers because those groups are currently the majority immigrant groups in the United States.

"Moreover, the Asian and Latino populations in the United States are expected to triple by mid-c
'"/>

Contact: Robert Bock or Marianne Glass Miller
bockr@mail.nih.gov
301-496-5133
NIH/National Institute of Child Health and Human Development
1-Nov-2004


Page: 1 2 3 4

Related medicine news :

1. Pediatricians wary about recommending complementary therapies
2. Pediatricians often underestimate substance abuse problems in adolescents
3. Pediatricians need more training on environmental health
4. Pediatricians are plentiful, but not in poorer states
5. Pediatricians and parents key to improving quality of childrens health care
6. Study Shows That Pediatricians Play Crucial Role In Violence Prevention
7. Disease testing for immigrants: Discrimination disguised as public health policy
8. Prevalence of obesity among immigrants increases with longer residency in US
9. Should compulsory screening of immigrants be part of UK public health policy?
10. Asian immigrants likely to see blood pressure rise
11. Among Puerto Ricans, immigrant status overrated as barrier to adequate prenatal care

Post Your Comments:
(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: